Latest news with #Curaleaf
Associated Press
28-05-2025
- Business
- Associated Press
DEA Marijuana Hypocrisy On Full Display: Why are U.S. Cannabis Companies Exporting Illegally While MMJ BioPharma Is Stonewalled?
'The Drug Enforcement Administration (DEA) is embroiled in a glaring contradiction: While federally compliant medical cannabis researchers like MMJ BioPharma Cultivation remain paralyzed by bureaucratic delays, U.S. recreational cannabis companies are openly exporting products, intellectual property and money to Europe -flouting federal law with no DEA intervention', stated Duane Boise, CEO MMJ. This double standard exposes a system prioritizing corporate profits over scientific progress and public health, undermining the DEA's mandate under the Controlled Substances Act (CSA). WASHINGTON, DC / ACCESS Newswire / May 28, 2025 / While federally compliant pharmaceutical cannabis researchers like MMJ BioPharma Cultivation remain blocked from growing marijuana for FDA-authorized clinical trials, U.S. recreational cannabis companies are quietly shipping marijuana products, IP, and profits across the Atlantic - with virtually no resistance from the Drug Enforcement Administration (DEA). This is not just a contradiction. It's a federal double standard that protects commercial profit over public health, sabotages scientific research, and undermines the DEA's credibility under the Controlled Substances Act. DEA Allows Illegal Cannabis Exports? According to a recent Forbes report, major U.S. cannabis companies - including Curaleaf, Cookies, and Active are aggressively expanding in Europe, despite marijuana remaining a Schedule I controlled substance under federal law. The DEA strictly prohibits interstate commerce and international export of THC-based cannabis without explicit DEA authorization. So how are these companies doing it? They exploit legal loopholes using foreign subsidiaries, licensing arrangements, and strategic partnerships, effectively laundering money and Schedule I products into global markets like Germany, Portugal, and the UK. Active, a U.S. vaporizer manufacturer, now derives over 5% of its revenue from European cannabis companies and expects to double that soon. And yet - no DEA raids, no shutdowns, no warning letters. MMJ BioPharma: Fully Compliant, Legally Paralyzed Contrast that with MMJ BioPharma Cultivation, which has: Since 2018, MMJ has been waiting for the DEA to issue a Schedule I bulk manufacturing registration to grow its research material. Instead of approval, MMJ received a legally and constitutionally defective Order to Show Cause, overseen by an ALJ whose appointment the DOJ itself has now conceded was unconstitutional. Why the delay? Because MMJ's business model doesn't align with recreational profits - it's built on scientific rigor, regulatory compliance, and public health impact. And in today's DEA, that seems to be a liability. Federal Dysfunction: Policy by Profit, Not by Science The DEA's inaction toward exporters and aggression toward MMJ reflects a broader bureaucratic rot. While state-licensed cannabis operators are treated as de facto legal - despite violating federal law daily - those seeking federal compliance for clinical research are punished with silence, obstruction, and delay. This is not enforcement. It's economic favoritism posing as policy. As Beau Whitney, founder of Whitney Economics, told Forbes: 'The U.S. market is state by state and dysfunctional… from an investment perspective, it's high risk, low return, which is upside down.' Will Terrance Cole Break the Cycle? Incoming DEA Administrator Terrance Cole inherits a mess: Cole's choice is simple: Time to Choose Between Cartels and Clinics MMJ BioPharma Cultivation has followed the law. It has built the infrastructure. It has earned FDA authorization. And yet, it is treated as an outsider by the very agency tasked with enabling lawful scientific research. Meanwhile, unlicensed exports are booming, and DEA looks the other way. If Terrance Cole DEA (administrator to be confirmed) and the Trump administration are serious about federal cannabis reform, medical research, and agency accountability, they must answer this question: Why is the DEA helping companies skirt the law overseas while blocking the one company that's trying to follow it at home? It's time to stop the DEA clown show, and let science lead. MMJ is represented by attorney Megan Sheehan. CONTACT: Madison Hisey [email protected] 203-231-8583 SOURCE: MMJ International Holdings press release
Yahoo
24-05-2025
- Business
- Yahoo
Why Curaleaf Got Investors Higher on Friday
Two factors propelled the shares slightly higher on the last trading day of the week. One piece of news came from Florida, the other from Pennsylvania. 10 stocks we like better than Curaleaf › One positive internal company development and another outside of its control helped propel Curaleaf (OTC: CURLF) stock into the win column on Friday. The marijuana company's shares ticked up by 1.5% that trading session, on a day when the S&P 500 index closed in the red at 0.4%. Weed stocks are generally unpopular and tend to trade down if anything, so the Friday rise was notable. The internal factor was Curaleaf's announcement that it has opened a new medical marijuana dispensary in Florida, specifically in the municipality of Punta Gorda. This adds to the company's already considerable presence in the Southeastern state, as it's the 67th Curaleaf outlet there. That in itself is reason to be more optimistic about Curaleaf. Florida is the third most populous state in this country, with a recent estimate of almost 23.4 million inhabitants. At the moment, it has only legalized medical marijuana; a vote to flip the switch on recreational cannabis fell short last November, but there is sufficient public support for a future effort to succeed. As for the external happening, some distance north in Pennsylvania lawmakers are making another run at legalizing recreational sale and consumption. On State Senator Sharif Street's podcast, the lawmaker waxed optimistic with his guest, Representative Rick Krajewski, about their Democrat Party's attempts to modify the proposed law in order to get it passed. A legalization bill had passed in the House of Representatives earlier this month, but it was rejected by the Senate's law and justice committee when handed over to that legislative body. Both of these developments aren't all that major or game-changing, yet they are steps in the right direction for Curaleaf (and for the ever-struggling marijuana business in general). Investors are justified in feeling cautiously bullish about one and both, although Curaleaf needs bigger wins to be a more viable company. Before you buy stock in Curaleaf, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Curaleaf wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $640,662!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $814,127!* Now, it's worth noting Stock Advisor's total average return is 963% — a market-crushing outperformance compared to 168% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of May 19, 2025 Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Why Curaleaf Got Investors Higher on Friday was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
23-05-2025
- Business
- Yahoo
Curaleaf Strengthens Florida Presence with Punta Gorda Dispensary Opening
New location in Southwest Florida brings store count to 67 statewide, and 153 nationwide STAMFORD, Conn., May 23, 2025 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced the opening of a new medical cannabis dispensary in Punta Gorda, Florida. Curaleaf Punta Gorda, located at 100 Madrid Blvd., Suite 511, Punta Gorda, FL 33950, will begin welcoming medical patients on May 23, 2025. This expansion marks the Company's 67th store in Florida, bringing its nationwide store count to 153 stores. Curaleaf Punta Gorda, located in the heart of Charlotte County, is the Company's third dispensary in the region. The new location is situated amid historic landmarks, unique shopping and dining, and scenic outdoor attractions, including the popular Harborwalk trail and Fishermen's Village waterfront destination. The dispensary will offer Curaleaf's Select product line, including Select BRIQ all-in-one vapes and the new Select RSO X-Bites. It will also feature additional brands from the company's portfolio, such as Anthem pre-rolls, the brand-new Grassroots Dark Heart Collection, and Reef, a Florida-exclusive flower brand launched this year to provide even greater consistency and high-quality flower for medical patients. All of these products, and more, are sold exclusively at Curaleaf Florida medical dispensaries. Curaleaf Punta Gorda will operate from 9:00 a.m. to 8:30 p.m. ET Monday through Saturday and 10:00 a.m. to 7:00 p.m. ET on Sundays, with knowledgeable team members onsite to guide registered medical patients through their shopping experience. "Our reach continues to grow across Florida, with 67 stores serving patients in both metropolitan hubs and hyperlocal communities, including our newly opened hemp-focused retail store, The Hemp Company West Palm Beach, which we recently launched to meet adult hemp consumers where they are," said Boris Jordan, Chairman and CEO of Curaleaf. "With a strong statewide presence, we have developed a deep understanding of the unique needs of Floridians and take pride in offering a retail and product experience that reflects our commitment to serving both registered medical patients and now, adult hemp consumers. Our Florida flower brand, Reef, is a testament to this dedication, and its growing popularity has driven us to continually enhance quality to meet the expectations of our patients. As we expand our footprint, we remain dedicated to delivering products and services that our valued Florida communities can trust." This week, Curaleaf Florida announced a new patient discount structure, offering new patients 60% off their first three visits. Curaleaf also offers everyday discounts to senior citizens, students, veterans and their spouses. Furthermore, patients can benefit from a generous referral component, giving current patients $10 off and awarding $10 to referred friends who are currently registered Florida medical patients. Curaleaf Punta Gorda will host a grand opening and ribbon-cutting celebration on Friday, May 30, 2025 from 11:00 AM to 3:00 PM ET, featuring live music, giveaways, gifts with purchase, and promotions. For more information on Curaleaf's locations, patient resources, delivery program, and products in Florida, please visit About Curaleaf HoldingsCuraleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf, Select, Grassroots, Find, Anthem and The Hemp Company provide industry-leading service, product selection and accessibility across the medical and adult use markets. Curaleaf International is powered by a strong presence in all stages of the supply chain. Its unique distribution network throughout Europe, Canada and Australasia brings together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Toronto Stock Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit Forward Looking Statements:This media advisory contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward–looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-looking terminology such as "plans", "expects" or "proposed", "is expected", "intends", "anticipates", or "believes", or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. More particularly and without limitation, this news release contains forward-looking statements and information concerning the opening of a dispensary in Punta Gorda, Florida. Such forward-looking statements and information reflect management's current beliefs and are based on assumptions made by and information currently available to the company with respect to the matter described in this new release. Forward-looking statements involve risks and uncertainties, which are based on current expectations as of the date of this release and subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Additional information about these assumptions and uncertainties is contained under "Risk Factors and Uncertainties" in the Company's latest annual information form filed on March 3, 2025, which is available under the Company's SEDAR profile at and in other filings that the Company has made and may make with applicable securities authorities in the future. Forward-looking statements contained herein are made only as to the date of this press release and we undertake no obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. We caution investors not to place considerable reliance on the forward-looking statements contained in this press release. The Toronto Stock Exchange has not reviewed, approved or disapproved the content of this news release. Contacts: Investor Contact:Curaleaf Holdings, Lyon, Chief Investment OfficerIR@ Media Contact:Curaleaf Holdings, Rahmil, VP Public Relationsmedia@ View original content to download multimedia: SOURCE Curaleaf Holdings, Inc. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Associated Press
23-05-2025
- Business
- Associated Press
Curaleaf Strengthens Florida Presence with Punta Gorda Dispensary Opening
New location in Southwest Florida brings store count to 67 statewide, and 153 nationwide STAMFORD, Conn., May 23, 2025 /CNW/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ('Curaleaf' or the 'Company'), a leading international provider of consumer cannabis products, today announced the opening of a new medical cannabis dispensary in Punta Gorda, Florida. Curaleaf Punta Gorda, located at 100 Madrid Blvd., Suite 511, Punta Gorda, FL 33950, will begin welcoming medical patients on May 23, 2025. This expansion marks the Company's 67th store in Florida, bringing its nationwide store count to 153 stores. Curaleaf Punta Gorda, located in the heart of Charlotte County, is the Company's third dispensary in the region. The new location is situated amid historic landmarks, unique shopping and dining, and scenic outdoor attractions, including the popular Harborwalk trail and Fishermen's Village waterfront destination. The dispensary will offer Curaleaf's Select product line, including Select BRIQ all-in-one vapes and the new Select RSO X-Bites. It will also feature additional brands from the company's portfolio, such as Anthem pre-rolls, the brand-new Grassroots Dark Heart Collection, and Reef, a Florida-exclusive flower brand launched this year to provide even greater consistency and high-quality flower for medical patients. All of these products, and more, are sold exclusively at Curaleaf Florida medical dispensaries. Curaleaf Punta Gorda will operate from 9:00 a.m. to 8:30 p.m. ET Monday through Saturday and 10:00 a.m. to 7:00 p.m. ET on Sundays, with knowledgeable team members onsite to guide registered medical patients through their shopping experience. 'Our reach continues to grow across Florida, with 67 stores serving patients in both metropolitan hubs and hyperlocal communities, including our newly opened hemp-focused retail store, The Hemp Company West Palm Beach, which we recently launched to meet adult hemp consumers where they are,' said Boris Jordan, Chairman and CEO of Curaleaf. 'With a strong statewide presence, we have developed a deep understanding of the unique needs of Floridians and take pride in offering a retail and product experience that reflects our commitment to serving both registered medical patients and now, adult hemp consumers. Our Florida flower brand, Reef, is a testament to this dedication, and its growing popularity has driven us to continually enhance quality to meet the expectations of our patients. As we expand our footprint, we remain dedicated to delivering products and services that our valued Florida communities can trust.' This week, Curaleaf Florida announced a new patient discount structure, offering new patients 60% off their first three visits. Curaleaf also offers everyday discounts to senior citizens, students, veterans and their spouses. Furthermore, patients can benefit from a generous referral component, giving current patients $10 off and awarding $10 to referred friends who are currently registered Florida medical patients. Curaleaf Punta Gorda will host a grand opening and ribbon-cutting celebration on Friday, May 30, 2025 from 11:00 AM to 3:00 PM ET, featuring live music, giveaways, gifts with purchase, and promotions. For more information on Curaleaf's locations, patient resources, delivery program, and products in Florida, please visit About Curaleaf Holdings Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ('Curaleaf') is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf, Select, Grassroots, Find, Anthem and The Hemp Company provide industry-leading service, product selection and accessibility across the medical and adult use markets. Curaleaf International is powered by a strong presence in all stages of the supply chain. Its unique distribution network throughout Europe, Canada and Australasia brings together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Toronto Stock Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit Forward Looking Statements: This media advisory contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward–looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-looking terminology such as 'plans', 'expects' or 'proposed', 'is expected', 'intends', 'anticipates', or 'believes', or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. More particularly and without limitation, this news release contains forward-looking statements and information concerning the opening of a dispensary in Punta Gorda, Florida. Such forward-looking statements and information reflect management's current beliefs and are based on assumptions made by and information currently available to the company with respect to the matter described in this new release. Forward-looking statements involve risks and uncertainties, which are based on current expectations as of the date of this release and subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Additional information about these assumptions and uncertainties is contained under 'Risk Factors and Uncertainties' in the Company's latest annual information form filed on March 3, 2025, which is available under the Company's SEDAR profile at and in other filings that the Company has made and may make with applicable securities authorities in the future. Forward-looking statements contained herein are made only as to the date of this press release and we undertake no obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. We caution investors not to place considerable reliance on the forward-looking statements contained in this press release. The Toronto Stock Exchange has not reviewed, approved or disapproved the content of this news release. Contacts: Investor Contact: Curaleaf Holdings, Inc. Camilo Lyon, Chief Investment Officer [email protected] Media Contact: Curaleaf Holdings, Inc. Jordon Rahmil, VP Public Relations [email protected] View original content to download multimedia: SOURCE Curaleaf Holdings, Inc.
Cision Canada
23-05-2025
- Business
- Cision Canada
Curaleaf Strengthens Florida Presence with Punta Gorda Dispensary Opening
New location in Southwest Florida brings store count to 67 statewide, and 153 nationwide STAMFORD, Conn., May 23, 2025 /CNW/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced the opening of a new medical cannabis dispensary in Punta Gorda, Florida. Curaleaf Punta Gorda, located at 100 Madrid Blvd., Suite 511, Punta Gorda, FL 33950, will begin welcoming medical patients on May 23, 2025. This expansion marks the Company's 67 th store in Florida, bringing its nationwide store count to 153 stores. Curaleaf Punta Gorda, located in the heart of Charlotte County, is the Company's third dispensary in the region. The new location is situated amid historic landmarks, unique shopping and dining, and scenic outdoor attractions, including the popular Harborwalk trail and Fishermen's Village waterfront destination. The dispensary will offer Curaleaf's Select product line, including Select BRIQ all-in-one vapes and the new Select RSO X-Bites. It will also feature additional brands from the company's portfolio, such as Anthem pre-rolls, the brand-new Grassroots Dark Heart Collection, and Reef, a Florida-exclusive flower brand launched this year to provide even greater consistency and high-quality flower for medical patients. All of these products, and more, are sold exclusively at Curaleaf Florida medical dispensaries. Curaleaf Punta Gorda will operate from 9:00 a.m. to 8:30 p.m. ET Monday through Saturday and 10:00 a.m. to 7:00 p.m. ET on Sundays, with knowledgeable team members onsite to guide registered medical patients through their shopping experience. "Our reach continues to grow across Florida, with 67 stores serving patients in both metropolitan hubs and hyperlocal communities, including our newly opened hemp-focused retail store, The Hemp Company West Palm Beach, which we recently launched to meet adult hemp consumers where they are," said Boris Jordan, Chairman and CEO of Curaleaf. "With a strong statewide presence, we have developed a deep understanding of the unique needs of Floridians and take pride in offering a retail and product experience that reflects our commitment to serving both registered medical patients and now, adult hemp consumers. Our Florida flower brand, Reef, is a testament to this dedication, and its growing popularity has driven us to continually enhance quality to meet the expectations of our patients. As we expand our footprint, we remain dedicated to delivering products and services that our valued Florida communities can trust." This week, Curaleaf Florida announced a new patient discount structure, offering new patients 60% off their first three visits. Curaleaf also offers everyday discounts to senior citizens, students, veterans and their spouses. Furthermore, patients can benefit from a generous referral component, giving current patients $10 off and awarding $10 to referred friends who are currently registered Florida medical patients. Curaleaf Punta Gorda will host a grand opening and ribbon-cutting celebration on Friday, May 30, 2025 from 11:00 AM to 3:00 PM ET, featuring live music, giveaways, gifts with purchase, and promotions. For more information on Curaleaf's locations, patient resources, delivery program, and products in Florida, please visit About Curaleaf Holdings Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf, Select, Grassroots, Find, Anthem and The Hemp Company provide industry-leading service, product selection and accessibility across the medical and adult use markets. Curaleaf International is powered by a strong presence in all stages of the supply chain. Its unique distribution network throughout Europe, Canada and Australasia brings together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Toronto Stock Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit Forward Looking Statements: This media advisory contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward–looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-looking terminology such as "plans", "expects" or "proposed", "is expected", "intends", "anticipates", or "believes", or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. More particularly and without limitation, this news release contains forward-looking statements and information concerning the opening of a dispensary in Punta Gorda, Florida. Such forward-looking statements and information reflect management's current beliefs and are based on assumptions made by and information currently available to the company with respect to the matter described in this new release. Forward-looking statements involve risks and uncertainties, which are based on current expectations as of the date of this release and subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Additional information about these assumptions and uncertainties is contained under "Risk Factors and Uncertainties" in the Company's latest annual information form filed on March 3, 2025, which is available under the Company's SEDAR profile at and in other filings that the Company has made and may make with applicable securities authorities in the future. Forward-looking statements contained herein are made only as to the date of this press release and we undertake no obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. We caution investors not to place considerable reliance on the forward-looking statements contained in this press release. The Toronto Stock Exchange has not reviewed, approved or disapproved the content of this news release. Contacts: Investor Contact: Curaleaf Holdings, Inc. Camilo Lyon, Chief Investment Officer [email protected] Media Contact: Curaleaf Holdings, Inc. Jordon Rahmil, VP Public Relations [email protected] SOURCE Curaleaf Holdings, Inc.
